We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Dr Faith Matcham is the NIHR Maudsley BRC Research Champion for diversity and inclusion. Faith also co-ordinates the major depression study within RADAR-CNS, which uses data collected from wearable devices and smartphone sensors to predict health outcomes in people with major depressive disorder, epilepsy and MS.
By NIHR Maudsley BRC at 19 Apr 2021
Researchers at King’s College London have found that an important brain mechanism that allows us to switch between thinking about two or more ideas may help treat patients with schizophrenia who do not respond well to current treatments.
By NIHR Maudsley BRC at 1 Apr 2021Parallel™ is the first prescription only digital therapeutic to provide cognitive behavioural therapy (CBT) to adults with irritable bowel syndrome (IBS) to receive the FDA Marketing Authorization in the US. ParallelTM has also obtained a CE mark and been recommended for Evaluation in Practice by the National Institute for Health and Care Excellence (NICE).
By NIHR Maudsley BRC at 1 Apr 2021
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2025 | All rights reserved.
